Market Research in the Healthcare Field with Expertise in Medical Imaging and Radioisotopes

Bio-Tech Systems, Inc. - 4167 West Pinecrest Circle - Las Vegas, Nevada 89121 phone: (702) 456-7608 - fax: (702) 456-2189


	HOME

	ABOUT BIO-TECH SYSTEMS

	AUTHOR'S C.V.

	CLIENT LIST

	BREAKING MARKET NEWS

	REPORT #310 The U.S. Market for SPECT and PET Radiopharmaceuticals New! Released in Feb. 2010!

	REPORT #300 The Market for PET Radiopharmaceuticals & PET Imaging New! Released in Jul. 2009!

	REPORT #290 The U.S. Market for Brachytherapy Products New! Released in Mar. 2009!

	REPORT #260 The U.S. Market for Medical Imaging Contrast Media

	REPORT #230 The World Market for Therapeutic Radiopharmaceuticals

	ORDERS

	NEWS RELEASES

	CONTACT US

Growing Demand for PET Procedures Should Help Market Prospects

Feb. 5, 2005

PET procedure volume increased 48% in 2003 reaching 650,000 procedures. By 2010, PET procedure volume should rise to 2.1 million procedures. New PET radiopharmaceuticals and better synergy with CT and MR should help to increase demand for PET.

Although the dominant focus of PET is still in oncology, cardiology applications have been growing in diagnosing myocardial viability and follow-up to equivocal SPECT studies. This has allowed cardiologists more flexibility in using PET to diagnose patients with poor myocardial performance. The expanded role of PET in cardiology has also been stimulated by the growth of PET-CT with multi-slice CT configurations suitable for cardiac imaging.

Based on the positive outlook for PET, Bio-Tech Systems estimates that procedure volume will grow at a compound rate of about 20% per year in 2005 and 2006 and should reach about 2 million procedures by 2010. This is a conservative estimate since the synergy of PET with other imaging and diagnostic modalities could contribute to more rapid growth. Further information is available in Bio-Tech Systems' Report 200, Market for PET Radiopharmaceuticals and PET Imaging. This report analyzes the driving forces behind the growth of PET and provides a rationale for forecasting future utilization of this modality.

by Marvin Burns
Feb. 5, 2005

BIO-TECH SYSTEMS, INC., founded in 1980, provides clients with market research services in the healthcare field. This focuses on strategic planning, market research and development of new business opportunities. Bio Tech specializes in product and market evaluation where technical insight is important as well as the ability to communicate with many levels of management and end-users. One objective is to assess technological risk and target new products and services effectively in order to generate the best market response. Bio-Tech's expertise is in medical imaging and radioisotope products covering a broad range of diagnostic and therapeutic applications. For further details and information, please visit us at:

BIO-TECH SYSTEMS, INC.'s website of www.biotechsystems.com

View all Breaking Market News

Related Reading:

	Long-Term Opportunities in SPECT Despite Technetium Shortage	(May 12, 2010)

	New Technology Spurs Investment in Brachytherapy	(Apr 13, 2009)

	Rising Demand for PET Despite Reimbursement Pressure	(Sept. 3, 2008)

	Can SPECT-CT Revitalize Nuclear Medicine?	(Feb. 23, 2008)

	New Growth for Diagnostic Radiopharmaceuticals	(Oct. 6, 2006)

	New Promise for Therapeutic Radiopharmaceuticals	(Mar. 19, 2006)

	Changing Market for PET Brings Challenges and Opportunities	(Mar. 1, 2005)

	PET Reimbursement for Alzheimer's Will Have Significant Market Impact	(Jan. 10, 2005)

	Good Market Growth Should Continue for Contrast Media	(Dec. 15, 2004)

	Marketing Challenges Continue for Ultrasound Contrast Media	(Nov. 20, 2004)

	Bio-Tech PET Report	(Jul. 15, 2009)

	Bio-Tech Brachytherapy Report	(Mar. 25, 2009)

	Bio-Tech Diagnostic Radiopharmaceuticals Report	(Mar. 1, 2008)

	Bio-Tech Contrast Media Report	(Feb. 18, 2007)

	Bio-Tech Therapeutic Radiopharmaceuticals Report	(Feb. 10, 2006)

Send this page to a friend